ReviewStem cell reports2025
Community and bioethicists' perspectives on iPSC research with biobanked samples collected using broad consent.
Review in Stem cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Representational Veracity in Data Science Health Research: Targets, Proxies, Labels, and Descriptors.Journal of medical Internet research · 2026Article
- The Continuity Trap in Data Science Health Research.Journal of medical Internet research · 2026Article
- When does broad consent expire? A temporal validity framework for biobank samples in induced pluripotent stem cell research.Research square · 2026Article
- From Acceptable Profit to Fair Return: Operational Benefit-Sharing Models for Induced Pluripotent Stem Cell Research Using Legacy Samples from Low- and Middle-Income Countries.Research square · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Using anonymized, biobanked samples for induced pluripotent stem cells (iPSCs) creates new and unresolved ethical dilemmas. To elucidate the issues, we studied the perspectives of community members and bioethicists involved in the collection of the Yoruba Resident in Ibadan, Nigeria (YRI) HapMap samples. We found support for broad consent, commercial use of samples, more benefit sharing, sustained engagement of the community and local researchers, particularly for novel research, where a long time has elapsed between samples' collection and new research projects, and in the oversight of biobanked samples. Broad consent was durable when coupled with sustained community engagement, transparent governance, and practical mechanisms for reciprocal benefit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.